155 related articles for article (PubMed ID: 38513340)
1. Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities.
Ampomah-Wireko M; Chen S; Li R; Gao C; Wang M; Qu Y; Kong H; Nininahazwe L; Zhang E
Eur J Med Chem; 2024 Apr; 269():116326. PubMed ID: 38513340
[TBL] [Abstract][Full Text] [Related]
2. Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
Yuan S; Shen DD; Bai YR; Zhang M; Zhou T; Sun C; Zhou L; Wang SQ; Liu HM
Eur J Med Chem; 2023 Mar; 250():115239. PubMed ID: 36893700
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives.
Liu P; Jiang Y; Jiao L; Luo Y; Wang X; Yang T
J Med Chem; 2023 Oct; 66(20):13860-13873. PubMed ID: 37807849
[TBL] [Abstract][Full Text] [Related]
5. Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs.
Zhao Q; Xin L; Liu Y; Liang C; Li J; Jian Y; Li H; Shi Z; Liu H; Cao W
J Med Chem; 2021 Aug; 64(15):10557-10580. PubMed ID: 34260235
[TBL] [Abstract][Full Text] [Related]
6. An Update on the Structure of Oxazolidinone Analogs and a Comparison with Linezolid in Terms of In Vitro and Intracellular Efficacy against Clinically Relevant Bacterial Species.
Tang Q; Zhao Y; Xu B; Gong P; Wang D
Jpn J Infect Dis; 2017 Nov; 70(6):678-681. PubMed ID: 28890512
[TBL] [Abstract][Full Text] [Related]
7. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review.
Jiang D; Liu B; Gao T
Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161
[TBL] [Abstract][Full Text] [Related]
8. Oxazolidinone antimicrobials: a patent review (2012-2015).
Phillips OA; Sharaf LH
Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
11. Novel piperidinyloxy oxazolidinone antibacterial agents. Diversification of the N-Substituent.
Weidner-Wells MA; Boggs CM; Foleno BD; Melton J; Bush K; Goldschmidt RM; Hlasta DJ
Bioorg Med Chem; 2002 Jul; 10(7):2345-51. PubMed ID: 11983532
[TBL] [Abstract][Full Text] [Related]
12. Recent development of potent analogues of oxazolidinone antibacterial agents.
Michalska K; Karpiuk I; Król M; Tyski S
Bioorg Med Chem; 2013 Feb; 21(3):577-91. PubMed ID: 23273607
[TBL] [Abstract][Full Text] [Related]
13. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the identification of novel oxazolidinone antibacterial agents.
Renslo AR; Luehr GW; Gordeev MF
Bioorg Med Chem; 2006 Jun; 14(12):4227-40. PubMed ID: 16527486
[TBL] [Abstract][Full Text] [Related]
15. Novel oxazolidinone-quinolone hybrid antimicrobials.
Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
[TBL] [Abstract][Full Text] [Related]
16. The discovery of linezolid, the first oxazolidinone antibacterial agent.
Ford CW; Zurenko GE; Barbachyn MR
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):181-99. PubMed ID: 12455414
[TBL] [Abstract][Full Text] [Related]
17. Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
Brenciani A; Morroni G; Schwarz S; Giovanetti E
J Antimicrob Chemother; 2022 Sep; 77(10):2596-2621. PubMed ID: 35989417
[TBL] [Abstract][Full Text] [Related]
18. The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.
Thomasco LM; Gadwood RC; Weaver EA; Ochoada JM; Ford CW; Zurenko GE; Hamel JC; Stapert D; Moerman JK; Schaadt RD; Yagi BH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4193-6. PubMed ID: 14622999
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
[TBL] [Abstract][Full Text] [Related]
20. Structure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens.
Hu Z; Leus IV; Chandar B; Sherborne BS; Avila QP; Rybenkov VV; Zgurskaya HI; Duerfeldt AS
J Med Chem; 2022 Oct; 65(20):14144-14179. PubMed ID: 36257060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
